Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.

Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O.

Dig Liver Dis. 2018 Jan 31. pii: S1590-8658(18)30168-3. doi: 10.1016/j.dld.2018.01.132. [Epub ahead of print]

PMID:
29429910
2.

Prediction of Hepatic Encephalopathy: Why disregard well known risk factors?

Ridola L, Riggio O.

Hepatology. 2018 Jan 29. doi: 10.1002/hep.29808. [Epub ahead of print] No abstract available.

PMID:
29377250
3.

A low muscle mass increases mortality in compensated cirrhotic patients with sepsis.

Lucidi C, Lattanzi B, Di Gregorio V, Incicco S, D'Ambrosio D, Venditti M, Riggio O, Merli M.

Liver Int. 2018 Jan 11. doi: 10.1111/liv.13691. [Epub ahead of print]

PMID:
29323441
4.

The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.

De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, Forlino M, Farcomeni A, Riggio O.

J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907. [Epub ahead of print]

PMID:
28753738
5.

A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients.

Lucidi C, Di Gregorio V, Ceccarelli G, Venditti M, Riggio O, Merli M.

Clinicoecon Outcomes Res. 2017 Jun 29;9:385-390. doi: 10.2147/CEOR.S130725. eCollection 2017.

6.

Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis.

Carnevale R, Raparelli V, Nocella C, Bartimoccia S, Novo M, Severino A, De Falco E, Cammisotto V, Pasquale C, Crescioli C, Scavalli AS, Riggio O, Basili S, Violi F.

J Hepatol. 2017 Nov;67(5):950-956. doi: 10.1016/j.jhep.2017.07.002. Epub 2017 Jul 14.

PMID:
28716745
7.

The animal naming test: An easy tool for the assessment of hepatic encephalopathy.

Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, Pasquale C, Nardelli S, Pentassuglio I, Merkel C, Angeli P, Riggio O, Amodio P.

Hepatology. 2017 Jul;66(1):198-208. doi: 10.1002/hep.29146. Epub 2017 May 27.

PMID:
28271528
8.

Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.

Nardelli S, Allampati S, Riggio O, Mullen KD, Prakash R, Gioia S, Unser A, White MB, Fagan AC, Wade JB, Farcomeni A, Gavis EA, Bajaj JS.

Dig Dis Sci. 2017 Mar;62(3):794-800. doi: 10.1007/s10620-016-4425-6. Epub 2016 Dec 30.

PMID:
28039670
9.

Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.

Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, Merli M, Riggio O.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):934-936. doi: 10.1016/j.cgh.2016.10.028. Epub 2016 Nov 2.

PMID:
27816756
10.

Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass.

Merli M, Torromeo C, Giusto M, Iacovone G, Riggio O, Puddu PE.

Liver Int. 2017 May;37(5):700-706. doi: 10.1111/liv.13287. Epub 2016 Nov 19.

PMID:
27782364
11.

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek FWG, Valla D, Garcia-Pagan JC; VALDIG Investigators.

Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19.

PMID:
27778440
12.

Low-grade endotoxemia and platelet activation in cirrhosis.

Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, Violi F.

Hepatology. 2017 Feb;65(2):571-581. doi: 10.1002/hep.28853. Epub 2016 Nov 5.

PMID:
27641757
13.

Idiopathic noncirrhotic portal hypertension: current perspectives.

Riggio O, Gioia S, Pentassuglio I, Nicoletti V, Valente M, d'Amati G.

Hepat Med. 2016 Jul 27;8:81-8. doi: 10.2147/HMER.S85544. eCollection 2016. Review.

14.

Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors.

Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Nogas Sobrinho S, Pentassuglio I, Greco F, De Santis A, Merli M, Riggio O.

Dig Liver Dis. 2016 Sep;48(9):1072-7. doi: 10.1016/j.dld.2016.06.014. Epub 2016 Jun 30.

PMID:
27448844
15.

Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.

Lucidi C, Ginanni Corradini S, Abraldes JG, Merli M, Tandon P, Ferri F, Parlati L, Lattanzi B, Poli E, Di Gregorio V, Farcomeni A, Riggio O.

Liver Transpl. 2016 Oct;22(10):1333-42. doi: 10.1002/lt.24517.

16.

Portal Hypertension Related to Schistosomiasis Treated With a Transjugular Intrahepatic Portosystemic Shunt.

Grieco S, Sulekova LF, Nardelli S, Riggio O, Venditti M, Taliani G.

J Clin Gastroenterol. 2016 Aug;50(7):608-10. doi: 10.1097/MCG.0000000000000545. No abstract available.

PMID:
27159422
17.

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI).

Dig Liver Dis. 2016 May;48(5):455-467. doi: 10.1016/j.dld.2016.02.008. Epub 2016 Feb 27.

PMID:
27012444
18.

Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.

Nardelli S, Gioia S, Pasquale C, Pentassuglio I, Farcomeni A, Merli M, Salvatori FM, Nikolli L, Torrisi S, Greco F, Nicoletti V, Riggio O.

Am J Gastroenterol. 2016 Apr;111(4):523-8. doi: 10.1038/ajg.2016.29. Epub 2016 Mar 1.

PMID:
26925879
19.

AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.

Italian Association for the Study of the Liver (AISF); Italian Society of Transfusion Medicine and Immunohaematology (SIMTI).

Dig Liver Dis. 2016 Jan;48(1):4-15. doi: 10.1016/j.dld.2015.11.008. Review.

PMID:
26802734
20.

An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial.

Merli M, Lucidi C, Di Gregorio V, Lattanzi B, Giannelli V, Giusto M, Farcomeni A, Ceccarelli G, Falcone M, Riggio O, Venditti M.

Hepatology. 2016 May;63(5):1632-9. doi: 10.1002/hep.28332. Epub 2016 Jan 5.

PMID:
26529126

Supplemental Content

Loading ...
Support Center